Announcements Trials

Browse Landscape

Status

Completed 9 Terminated 5 Withdrawn 2 Unknown 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1

Conditions

Lymphoma 1 Lymphohistiocytosis, Hemophagocytic 1

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 17 obinutuzumab 11 venetoclax 9 Bendamustine Hydrochloride 9 Lenalidomide 8 zanubrutinib 6 Prednisone 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 fludarabine phosphate 5 Biopsy 5 ibrutinib 4 glofitamab 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Exercise 4 loncastuximab tesirine 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Mycophenolic Acid 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Flow Cytometry × Clear all

NCT06585124 2024-09-05

LA-HLH

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

LymphoidMyeloid

Lymphoma, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡